Ergothioneine-enhanced beverage concept for alzheimer’s prevention
A research concept explores using ergothioneine, a rare amino acid with potent antioxidant properties, as a preventive approach for Alzheimer’s disease. The compound is proposed to cross the blood-brain barrier via the OCTN1 transporter, supporting neuroprotective effects. The approach includes incorporating ergothioneine extract into beverages and conducting a longitudinal human study to evaluate cognitive benefits and effects on oxidative stress.
Overview
A research concept explores ergothioneine, a rare amino acid with potent antioxidant properties, as a preventive measure against Alzheimer’s disease. Ergothioneine is proposed to cross the blood-brain barrier via the OCTN1 transporter, enabling targeted delivery to the brain. The concept aims to leverage ergothioneine’s neuroprotective potential to help reduce neurodegenerative risk over time.
Technical specifications
Key features:
- Ergothioneine is extracted from mushrooms and has been shown to scavenge reactive oxygen species and transition metals in the brain, potentially reducing Alzheimer’s pathology.
- The compound’s ability to cross the blood-brain barrier via the OCTN1 transporter is proposed to make it particularly effective for brain health.
- Proposed formulation involves purchasing ergothioneine extract and incorporating it into beverages, followed by a longitudinal study to assess cognitive benefits.
Technology readiness level
This research is currently at Technology Readiness Level 4, indicating that the concept has been validated in a laboratory setting. Future steps involve formulating the beverage and conducting a human study to assess its effectiveness in preventing oxidative stress and improving cognitive function.
About Vanderbilt University Medical Center
Vanderbilt University Medical Center is a large, independent academic medical center and health system in Nashville, uniting patient care, research, and training at scale. Co-located hospitals and research facilities give partners access to core labs, biobanking, advanced imaging, and secure, de‑identified EHR data resources. A centralized trials office, experienced contracting, and proximity to Nashville’s healthcare management cluster streamline multi-site studies and real‑world evidence work. Research is backed by competitive federal funding, led by NIH and complemented by DoD and CDC. A dedicated technology transfer office supports IP, licensing, and startup formation to accelerate clinical translation.
delivered to your inbox.